|  | No anastomotic leakage | Anastomotic leakage | p value |
---|---|---|---|---|
Gender; n (%) | Female | 391 (93.8%) | 26 (6.2%) | 0.005 |
Male | 427 (88.4%) | 56 (11.6%) | ||
CCI; n (%) | ≤5 | 602 (92.6%) | 48 (7.4%) | 0.004 |
> 5 | 216 (86.4%) | 34 (13.6%) | ||
Ischemic heart disease; n (%) | Yes | 39 (90.7%) | 4 (9.3%) | 0.999 |
No | 779 (90.9%) | 78 (9.1%) | ||
Diabetes mellitus; n (%) | Yes | 82 (86.3%) | 13 (13.7%) | 0.101 |
No | 736 (91.4%) | 69 (8.6%) | ||
Cerebrovascular disease; n (%) | Yes | 25 (92.6%) | 2 (7.4%) | 0.999 |
No | 793 (90.8%) | 80 (9.2%) | ||
Chronic kidney failure; n (%) | Yes | 12 (92.3%) | 1 (7.7%) | 0.999 |
No | 806 (90.9%) | 81 (9.1%) | ||
Neoadjuvant treatment; n (%) | Yes | 169 (88.0%) | 23 (12.0%) | 0.119 |
No | 649 (91.7%) | 59 (8.3%) | ||
Tumor localization; n (%) | Rectum | 458 (89.3%) | 55 (10.7%) | 0.132 |
Rectosigmoid | 112 (91.8%) | 10 (8.2%) | ||
Sigmoid | 248 (93.6%) | 17 (6.4%) | ||
T; n (%) | T0–2 | 284 (94.4%) | 17 (5.6%) | 0.010 |
T3–4 | 534 (89.1%) | 65 (10.9%) | ||
M; n (%) | M0 | 740 (91.4%) | 70 (8.6%) | 0.142 |
M1 | 78 (86.7%) | 12 (13.3%) | ||
Stage; n (%) | 0 | 11 (91.7%) | 1 (8.3%) | 0.290 |
I | 221 (93.4%) | 15 (6.6%) | ||
II | 246 (91.4%) | 23 (8.6%) | ||
III | 272 (90.1%) | 30 (9.9%) | ||
IV | 78 (85.7%) | 13 (14.3%) | ||
Ligation of inferior mesenteric artery; n (%) | High | 631 (90.5%) | 66 (9.5%) | 0.610 |
Low | 167 (91.8%) | 15 (8.2%) | ||
Simultaneous operation; n (%) | Yes | 73 (86.9%) | 11 (13.1%) | 0.183 |
No | 745 (91.3%) | 71 (8.7%) | ||
Anastomosis level from anal verge; n (%) | ≤5 cm | 155 (89.1%) | 19 (10.9%) | 0.023 |
6–12 cm | 255 (87.0%) | 38 (13.0%) | ||
> 12 cm | 259 (93.8%) | 17 (6.2%) | ||
Approach of surgery; n (%) | Open | 391 (88.5%) | 51 (11.5%) | 0.013 |
Minimally invasive | 427 (93.2%) | 31 (6.8%) | ||
Age; n (%) | NE group (≤75 years) | 675 (91.5%) | 63 (8.5%) | 0.201 |
E group (>75 years) | 143 (88.3%) | 19 (11.7%) |